Agios Pharmaceuticals, Inc. (AGIO)
37.00
-0.19
(-0.51%)
USD |
NASDAQ |
Oct 23, 16:00
37.00
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Market Cap : 2.205B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.205B |
| October 22, 2026 | 2.217B |
| October 21, 2026 | 2.216B |
| October 20, 2026 | 2.184B |
| October 19, 2026 | 2.080B |
| October 16, 2026 | 1.867B |
| October 15, 2026 | 1.926B |
| October 14, 2026 | 1.846B |
| October 13, 2026 | 1.801B |
| October 12, 2026 | 1.837B |
| October 09, 2026 | 1.896B |
| October 08, 2026 | 1.903B |
| October 07, 2026 | 1.895B |
| October 06, 2026 | 1.891B |
| October 05, 2026 | 1.863B |
| October 02, 2026 | 1.895B |
| October 01, 2026 | 1.936B |
| September 30, 2026 | 1.982B |
| September 29, 2026 | 1.985B |
| September 28, 2026 | 1.992B |
| September 25, 2026 | 1.942B |
| September 24, 2026 | 1.961B |
| September 23, 2026 | 2.038B |
| September 22, 2026 | 2.084B |
| September 21, 2026 | 2.024B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.971B |
| September 17, 2026 | 2.003B |
| September 16, 2026 | 1.964B |
| September 15, 2026 | 1.956B |
| September 14, 2026 | 1.980B |
| September 11, 2026 | 2.003B |
| September 10, 2026 | 2.005B |
| September 09, 2026 | 2.064B |
| September 08, 2026 | 2.000B |
| September 04, 2026 | 1.973B |
| September 03, 2026 | 1.975B |
| September 02, 2026 | 2.034B |
| September 01, 2026 | 2.039B |
| August 31, 2026 | 2.007B |
| August 28, 2026 | 1.986B |
| August 27, 2026 | 2.043B |
| August 26, 2026 | 2.026B |
| August 25, 2026 | 2.021B |
| August 24, 2026 | 1.946B |
| August 21, 2026 | 1.972B |
| August 20, 2026 | 2.005B |
| August 19, 2026 | 2.093B |
| August 18, 2026 | 2.050B |
| August 17, 2026 | 2.005B |
| August 14, 2026 | 2.000B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Biogen, Inc. | 37.03B |
| Insmed, Inc. | 20.39B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Regeneron Pharmaceuticals, Inc. | 83.24B |
Market Cap Related Metrics
| PS Ratio | 22.08 |
| Price to Book Value | 2.149 |
| Price | 37.00 |
| Earnings Yield | -18.95% |